James D. Chalmers

Research interests

Publications

• Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

  The Lancet Respiratory Medicine · 2023 · https://doi.org/10.1016/s2213-2600(23)00093-0

• Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01273-9

• Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

  The Lancet Respiratory Medicine · 2022 · https://doi.org/10.1016/s2213-2600(22)00127-8

• Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

  The Lancet Respiratory Medicine · 2021 · https://doi.org/10.1016/s2213-2600(21)00383-0

• European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis

  European Respiratory Journal · 2021 · https://doi.org/10.1183/13993003.02990-2020

• Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

  The Lancet Respiratory Medicine · 2021 · https://doi.org/10.1016/s2213-2600(21)00277-0

• Pneumonia

  Nature Reviews Disease Primers · 2021 · https://doi.org/10.1038/s41572-021-00259-0

• Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals

  Critical Care Medicine · 2020 · https://doi.org/10.1097/ccm.0000000000004246

• Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

  CHEST Journal · 2020 · https://doi.org/10.1016/j.chest.2020.05.598

• Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa2021713

• Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity

  The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)31767-7

• Bronchiectasis

  Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/s41572-018-0042-3

• Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals

  Annals of the American Thoracic Society · 2018 · https://doi.org/10.1513/annalsats.201808-564ps

• Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients

  European Respiratory Journal · 2018 · https://doi.org/10.1183/13993003.01190-2017

• British Thoracic Society Guideline for bronchiectasis in adults

  Thorax · 2018 · https://doi.org/10.1136/thoraxjnl-2018-212463

• European Respiratory Society guidelines for the management of adult bronchiectasis

  European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00629-2017

• Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

  European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00051-2017

• Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis

  American Journal of Respiratory and Critical Care Medicine · 2017 · https://doi.org/10.1164/rccm.201605-1027oc

• Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study

  The Lancet Respiratory Medicine · 2016 · https://doi.org/10.1016/s2213-2600(16)30320-4

• The Bronchiectasis Severity Index. An International Derivation and Validation Study

  American Journal of Respiratory and Critical Care Medicine · 2014 · https://doi.org/10.1164/rccm.201309-1575oc

• Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis

  American Journal of Respiratory and Critical Care Medicine · 2012 · https://doi.org/10.1164/rccm.201203-0487oc

• Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis

  Thorax · 2010 · https://doi.org/10.1136/thx.2009.133280

• C-Reactive Protein Is an Independent Predictor of Severity in Community-acquired Pneumonia

  The American Journal of Medicine · 2008 · https://doi.org/10.1016/j.amjmed.2007.10.033

Current projects

No projects listed.